Company intelligence / Profile preview

Retinaplus

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

RetinaPlus is a medical technology company focused on transforming the management of chronic retinal diseases through advanced remote monitoring solutions. The company provides a platform that enables ophthalmologists to monitor patients with conditions such as age-related macular degeneration and diabetic retinopathy between office visits. By utilizing proprietary hardware and software, RetinaPlus facilitates early detection of disease progression, allowing for timely intervention and improved visual outcomes. Their services are designed to integrate seamlessly into clinical workflows, enhancing the standard of care for patients at risk of vision loss.

Therapeutic areas: Ophthalmology
Modalities: DeviceSoftware as a Medical Device
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Retinaplus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinaplus.

Explore the full profile